ロード中...
Treatment for Relapsed/Refractory Acute Myeloid Leukemia
Patients with relapsed or refractory (r/r) acute myeloid leukemia (AML) have a poor prognosis and treatment remains challenging. For the majority of r/r patients, allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment approach. Salvage therapy is given in order to r...
保存先:
| 出版年: | Hemasphere |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8171365/ https://ncbi.nlm.nih.gov/pubmed/34095756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000572 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|